| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 87.21 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Patients with DMO and good baseline VA, managed by observation, are of increased risk for VA loss if DRIL, HRF and EZ disruption are present at baseline. Earlier treatment with anti‐VEGF in these patients may potentially decrease the risk of VA loss at 12 months.
Descrição
Palavras-chave
Diabetes Diabetic macular oedema Diabetic retinopathy Good visual acuity Intravitreal therapy Macular Oedema Observation
Contexto Educativo
Citação
Busch, C., Okada, M., Zur, D., Fraser‐Bell, S., Rodríguez‐Valdés, P.J., Cebeci, Z., Lupidi, M., Fung, A.T., Gabrielle, P.‐H., Giancipoli, E., Chaikitmongkol, V., Laíns, I., Santos, A.R., Kunavisarut, P., Sala‐Puigdollers, A., Chhablani, J., Ozimek, M., Hilely, A., Degenhardt, V., Loewenstein, A., Iglicki, M., Rehak, M. and (2020), Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity. Acta Ophthalmol, 98: e801-e806. https://doi.org/10.1111/aos.14390